Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study.
García-García I, González-Delgado CA, Valenzuela-Silva CM, Díaz-Machado A, Cruz-Díaz M, Nodarse-Cuní H, Pérez-Pérez O, Bermúdez-Badell CH, Ferrero-Bibilonia J, Páez-Meireles R, Bello-Rivero I, Castro-Odio FR, López-Saura PA; FarmaPEG Study Group. García-García I, et al. Among authors: valenzuela silva cm. BMC Pharmacol. 2010 Nov 23;10:15. doi: 10.1186/1471-2210-10-15. BMC Pharmacol. 2010. PMID: 21092287 Free PMC article. Clinical Trial.
Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF, Casanova-González M, García-García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera-Valdés R, López-Saura PA; Bioequivalence Study of Erythropoietin Group. Pérez-Oliva JF, et al. BMC Nephrol. 2005 May 23;6:5. doi: 10.1186/1471-2369-6-5. BMC Nephrol. 2005. PMID: 15910687 Free PMC article. Clinical Trial.
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.
Milanés-Virelles MT, García-García I, Santos-Herrera Y, Valdés-Quintana M, Valenzuela-Silva CM, Jiménez-Madrigal G, Ramos-Gómez TI, Bello-Rivero I, Fernández-Olivera N, Sánchez-de la Osa RB, Rodríguez-Acosta C, González-Méndez L, Martínez-Sánchez G, López-Saura PA; MACGAM Study Group. Milanés-Virelles MT, et al. BMC Infect Dis. 2008 Feb 11;8:17. doi: 10.1186/1471-2334-8-17. BMC Infect Dis. 2008. PMID: 18267006 Free PMC article. Clinical Trial.
Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients.
Pentón-Rol G, Cervantes-Llanos M, Cabrera-Gómez JA, Alonso-Ramírez R, Valenzuela-Silva C, Rodríguez-Lara R, Montero-Casimiro E, Bello-Rivero I, López-Saura P. Pentón-Rol G, et al. Int Immunopharmacol. 2008 Jun;8(6):881-6. doi: 10.1016/j.intimp.2008.02.003. Epub 2008 Mar 5. Int Immunopharmacol. 2008. PMID: 18442793
TNF-alpha and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica.
Pentón-Rol G, Cervantes-Llanos M, Martínez-Sánchez G, Cabrera-Gómez JA, Valenzuela-Silva CM, Ramírez-Nuñez O, Casanova-Orta M, Robinson-Agramonte MA, Lopategui-Cabezas I, López-Saura PA. Pentón-Rol G, et al. Among authors: valenzuela silva cm. J Inflamm (Lond). 2009 Jun 2;6:18. doi: 10.1186/1476-9255-6-18. J Inflamm (Lond). 2009. PMID: 19490629 Free PMC article.
Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.
Fernández-Montequín JI, Valenzuela-Silva CM, Díaz OG, Savigne W, Sancho-Soutelo N, Rivero-Fernández F, Sánchez-Penton P, Morejón-Vega L, Artaza-Sanz H, García-Herrera A, González-Benavides C, Hernández-Cañete CM, Vázquez-Proenza A, Berlanga-Acosta J, López-Saura PA; Cuban Diabetic Foot Study Group. Fernández-Montequín JI, et al. Among authors: valenzuela silva cm. Int Wound J. 2009 Dec;6(6):432-43. doi: 10.1111/j.1742-481X.2009.00641.x. Int Wound J. 2009. PMID: 20051095 Free PMC article. Clinical Trial.
Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor.
Valenzuela-Silva CM, Tuero-Iglesias ÁD, García-Iglesias E, González-Díaz O, Del Río-Martín A, Yera Alos IB, Fernández-Montequín JI, López-Saura PA. Valenzuela-Silva CM, et al. Diabetes Care. 2013 Feb;36(2):210-5. doi: 10.2337/dc12-1323. Epub 2012 Sep 10. Diabetes Care. 2013. PMID: 22966096 Free PMC article. Clinical Trial.
Recombinant streptokinase suppositories in the treatment of acute haemorrhoidal disease. Multicentre randomized double-blind placebo-controlled trial (THERESA-2).
Hernández-Bernal F, Valenzuela-Silva CM, Quintero-Tabío L, Castellanos-Sierra G, Monterrey-Cao D, Aguilera-Barreto A, López-Saura P; THERESA-2 Group of Investigators. Hernández-Bernal F, et al. Among authors: valenzuela silva cm. Colorectal Dis. 2013 Nov;15(11):1423-8. doi: 10.1111/codi.12327. Colorectal Dis. 2013. PMID: 23809982 Clinical Trial.
Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers.
Yera-Alos IB, Alonso-Carbonell L, Valenzuela-Silva CM, Tuero-Iglesias AD, Moreira-Martínez M, Marrero-Rodríguez I, López-Mola E, López-Saura PA. Yera-Alos IB, et al. Among authors: valenzuela silva cm. BMC Pharmacol Toxicol. 2013 Sep 3;14:44. doi: 10.1186/2050-6511-14-44. BMC Pharmacol Toxicol. 2013. PMID: 24004460 Free PMC article.
18 results